SAN DIEGO, June 02, 2025 -- BioAtla, Inc. (Nasdaq: BCAB) (the “Company”), a global clinical-stage biotechnology company focused on the development of Conditionally Active Biologic (CAB) antibody therapeutics for the...
Art Pappas will speak at the Personalized Medicine in North Carolina: Innovation to Application conference that will be held in Research Triangle Park, NC: "Investors Perspectives on Investments in Personalized Medicine"
News | 05. 11. 2009
© 2025 Pappas Capital, LLC. ALL RIGHTS RESERVED.